We empower RNA scientists with deeper insights, driven by our core belief: more information fuels better science
Harnessing the power of translatomics
Our Mission
At EIRNABio, our mission is to harness the power of Translatomics – unlocking the secrets of how cells translate RNA into proteins – to help our clients and partners to accelerate therapeutic and biomarker discovery.
Our Name
We are often asked about our name. The word EIRNA is derived from a fusion of the Irish word for Ireland (Éire) and RNA (which of course underpins all translational processes). And (perhaps a little more obviously) the “Bio” in our name is short for Bioinnovation – reflecting the company’s innovative culture.
Our Journey
Our founders and scientific advisors are pioneers in the field of translatomics and have been at the vanguard of developing cutting-edge translatomics tools and interpretative techniques for many years.
As ribosome profiling (Ribo-Seq) gained traction, pharma and biotech companies sought their expertise in generating and interpreting Ribo-Seq data. Recognizing the demand, we established our company in 2017 as Ribomaps, specializing in ribosome profiling services. Through strong industry relationships—including three-quarters of the top 20 pharma companies—we expanded our proprietary platforms and became a leader in translatomics. In 2022, we rebranded as EIRNABio to reflect this broader expertise.
Our numbers Speak for themselves
3
Proprietary platforms that help accelerate therapeutic & biomarker discovery
300
Client projects successfully completed since we were founded
75
percent of the worlds top 20 pharma are our clients
50
Species, cell and tissue types on which we’ve worked
Rooted in our ELITE values system
We have earned the trust of our clients and partners by consistently delivering high-quality, insightful science that drives meaningful discoveries. From the moment they engage with EIRNABio, they experience a culture that goes beyond just words—it’s evident in every interaction. Rooted in our ELITE values system of Excellence, Leadership, Integrity, Teamwork and Environment, this culture shapes how we work internally and is the foundation of the strong, long-term partnerships we build.
Excellence
We pursue excellence in every aspect of our work. From project design and execution to clear, insightful communication of results, we ensure that every step aligns with our clients' key objectives.
Leadership
We are pioneers in translatomics, continuously driving the field forward. Our expertise allows us to deliver cutting-edge insights that accelerate, enhance, and de-risk early-stage discovery and development.
Integrity
Scientific, professional, and personal integrity is at the heart of what we do. We provide unfiltered, objective insights so that you can rely on our data with absolute confidence.
Teamwork
At our core, we are scientists who love collaboration. We roll up our sleeves, work alongside you, and tackle complex biological challenges together—because breakthroughs happen when great minds join forces.
Environment
Our logo tagline “Enabling Bioinnovations” reflects the environment we cultivate—one where our scientists thrive in innovation and ambition. By fostering this mindset internally, we empower our clients to push boundaries in their own research.
Integrity
Scientific, professional, and personal integrity is at the heart of what we do. We provide unfiltered, objective insights so that you can rely on our data with absolute confidence.
Meet our Scientific Advisory Board
Professor John Atkins
John Atkins is Professor Emeritus at University College Cork and University of Utah. He is globally recognized in translatomics for pioneering non-standard decoding, including programmed ribosomal frameshifting and recoding mechanisms.
Professor Nicholas Ingolia
Nicholas Ingolia is a UC Berkeley professor and globally acknowledged as a pioneer of ribosome profiling. His research focuses on mRNA translation control, RNA-binding proteins, and gene regulatory networks using high-throughput techniques.
Professor Jonathan Weissman
Jonathan Weissman is one of the globally-recognized pioneers of ribosome profiling and currently professor at MIT and the Whitehead Institute, researching protein folding, misfolding diseases, and ribosome profiling.
Professor Allen Buskirk
Allen Buskirk is a Research Associate at Johns Hopkins. A close collaborator of Rachel Green, he develops advanced ribosome profiling methods to study translation dynamics, stalling, and ribosome rescue mechanisms in bacteria.
Engage with our Translatomics experts!